SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors weigh the potential for a transformative buyout ahead of a long-awaited trial event, while the community remains sharply divided between bulls anticipating a massive premium and bears expressing skepticism over trial timelines and asset efficacy.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing a massive parabolic rally fueled by severe NAND flash and SSD supply constraints, with community sentiment deeply polarized between retail investors chasing the momentum and bears warning of an unsustainable AI-driven bubble. Traders are closely monitoring the impact of Apple's recent memory price hikes and upcoming Micron earnings, as the community debates whether the stock represents a structural growth story or a historic speculative mania.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is trending as traders closely monitor escalating geopolitical tensions in the Strait of Hormuz and the status of US-Iran negotiations, which remain a primary driver of market sentiment. The community is actively debating the sustainability of the current AI-led market rally, with many investors weighing the risks of high capital expenditures against potential economic instability and rising interest rates.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant momentum as investors digest unconfirmed reports of a domestic chip manufacturing partnership with Apple, further fueled by government-backed foundry initiatives. The stock remains a focal point for community debate, with traders weighing a potential multi-year turnaround narrative against concerns that current price levels may already be extended following a period of rapid appreciation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant community attention as investors position for imminent long-term efficacy results from the VELA Phase 3 program, which many view as a critical rerating catalyst. With institutional interest rising and active discussions focused on the potential for superior clinical data compared to current market leaders, participants are closely monitoring the upcoming investor conference for possible M&A discussions or pipeline updates.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as the community scrutinizes the company's shift toward high-volume commercial scaling and its strategic expansion into smart glasses, drones, and wearable markets. Investors are actively debating the viability of the company's manufacturing throughput and the recent shift in battery qualification timelines, while monitoring the broader implications of its expanding supply chain partnerships across Asia.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing strong investor engagement driven by its structural positioning in the AI data center market and excitement surrounding upcoming product catalysts. The community is actively discussing the stock's role in the broader semiconductor sector rotation, focusing on its ability to capture long-term demand for compute power amidst shifting macroeconomic conditions.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility as investors balance excitement over its critical role in the optical networking infrastructure for AI data centers with concerns regarding production execution and repeated insider selling. Community discussions are heavily split between those targeting a breakout driven by AI-driven bandwidth demand and skeptics pointing to high valuations and dilution risks.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending as investors react to a significant partnership with Midjourney to integrate its ultrasound-on-chip technology into a new AI-powered full-body scanner. While the community is actively debating the stock's long-term potential as a semiconductor play versus immediate dilution risks and a 'sell-the-news' pullback, the stock has seen heightened volume and volatility as bulls look for a breakthrough of key resistance levels.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is gaining traction as traders debate its long-term utility in the IoT and data sovereignty space, while the community remains sharply divided between those accumulating at current levels and others dismissing the project as a speculative pump-and-dump cycle. Investor discourse is currently dominated by conflicting views on the project's ecosystem expansion versus concerns over historical price performance and tokenomics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nature's Sunshine Products (NATR) Expected to Announce Earnings on Thursday

Nature's Sunshine Products (NASDAQ:NATR) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Nature's Sunshine Products (NASDAQ:NATR) Shares Pass Above 200-Day Moving Average - What's Next?

Nature's Sunshine Products (NASDAQ:NATR) Shares Cross Above 200-Day Moving Average - Here's Why...

Daniel Norman Sells 15,383 Shares of Nature's Sunshine Products (NASDAQ:NATR) Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Daniel Norman sold 15,383 shares of the firm's stock in a transaction dated Friday, March 13th. The stock was sold at an average...

Insider Selling: Nature's Sunshine Products (NASDAQ:NATR) EVP Sells 19,516 Shares of Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Bryant Yates sold 19,516 shares of the firm's stock in a transaction on Friday, March 13th. The shares were sold at an average...

Insider Selling: Nature's Sunshine Products (NASDAQ:NATR) EVP Sells 15,383 Shares of Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Daniel Norman sold 15,383 shares of the company's stock in a transaction dated Friday, March 13th. The shares were sold at an...

Nature's Sunshine Products (NASDAQ:NATR) CAO Sells $98,800.00 in Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) CAO Jonathan David Lanoy sold 4,000 shares of Nature's Sunshine Products stock in a transaction that occurred on Friday, March 13th...

Nature's Sunshine Products (NASDAQ:NATR) CAO Jonathan David Lanoy Sells 4,000 Shares

Nature's Sunshine Products (NASDAQ:NATR) Price Target Raised to $33.00 at DA Davidson

DA Davidson raised their price target on shares of Nature's Sunshine Products from $23.00 to $33.00 and gave the company a "buy" rating in a research note on Thursday...

Nature's Sunshine Products Q4 Earnings Call Highlights

Nature's Sunshine Products (NASDAQ:NATR) reported fourth-quarter and full-year 2025 results that management described as record-setting, citing continued momentum in its digital business, increased...

Earnings Summary: Natures Sunshine Products Q4

Nature's Sunshine Products, Inc. engages in the manufacture and sale of nutritional and personal care products. Its product lines include general health, immune, cardiovascular, digestive, personal care, and weight management. It operates through the following geographical segments: Asia, Europe, North America, and Latin America and Other. The company was founded by Eugene L. Hughes, Kristine F. Hughes, and Pauline Hughes-Francis in 1972 and is headquartered in Lehi, UT.

Nature`s Sunshine Products, Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

NATRNature`s Sunshine Products, Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NATR News